Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07079358 · ClinicalTrials.gov registry record · NA
Improving Veteran Referral to Cardiac Rehabilitation
A NA study, sponsored by VA Office of Research and Development.
- Recruiting
- Registry status
- NA
- Development phase
- 816
- Enrollment target
NCT07079358: Recruiting NA study, sponsored by VA Office of Research and Development.
NCT07079358 is a NA study that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 816 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (42% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07079358, a NA study, is actively recruiting participants, sponsored by VA Office of Research and Development.
- RECRUITING
- Registry status
- NA
- Development phase
- 816 participants
- Enrollment target
Study Summary
This study will test whether the Veterans Cardiac Rehabilitation Referral Program (VCR2P) improves cardiac rehabilitation participation by studying 816 Veterans across three VA medical centers in Nashville, Dallas, and Gainesville over 12 months. The trial compares referral rates from the 6 months before implementing the program to 6 months after, using a "before and after" design since randomization would be impractical. The study will measure whether the program increases the proportion of eligible Veterans who receive cardiac rehabilitation referrals and whether more Veterans actually attend rehabilitation sessions. Additionally, focus groups with physicians, nurses, and Veterans will identify what helps or hinders the program's success, providing essential insights for expanding this intervention to other VA facilities nationwide if it proves effective.
Primary Outcome
Proportion of eligible Veterans referred to cardiac rehabilitation.
Interventions
- BEHAVIORAL Veterans Cardiac Rehabilitation Referral Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 816 participants |
| Start Date | 2026-02-23 |
| Est. Completion | 2029-12-31 |
| Phase | NA |
What NCT07079358 shows while recruiting
NCT07079358 is an interventional study that assigns participants to a tested intervention. The registered 816 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (42% lower).
The record links to 0 conditions, and to 1 intervention - of which Veterans Cardiac Rehabilitation Referral Program is the first listed.
NCT07079358 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07079358 about?
NCT07079358 is a clinical study titled "Improving Veteran Referral to Cardiac Rehabilitation". This study will test whether the Veterans Cardiac Rehabilitation Referral Program (VCR2P) improves cardiac rehabilitation participation by studying 816 Veterans across three VA medical centers in Nashville, Dallas, and Gainesville over 12 months. The trial compares referral rates from the 6 months b...
What is the current status of trial NCT07079358?
This trial is currently recruiting. It is a NA study. The enrollment target is 816 participants. The study started on 2026-02-23. Estimated completion is 2029-12-31.
What interventions are being tested in trial NCT07079358?
The interventions under investigation include: Veterans Cardiac Rehabilitation Referral Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT07079358?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07079358's enrollment target sits among peer trials
816 134th of 2000 higher than 1,867 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07218029 · 815 participants · Phase 3
A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)
- NCT04846959 · 818 participants
Study to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Exposed Pregnancies in Women With FDA Approved Indications
- NCT04028687 · 820 participants
MDR - PMCF Study for Taperloc Complete Stems
- NCT04613440 · 820 participants · NA
FaCT Trial (Facilitated Cascade Testing Trial)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI